{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,26]],"date-time":"2025-02-26T05:29:51Z","timestamp":1740547791168,"version":"3.38.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T00:00:00Z","timestamp":1740441600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T00:00:00Z","timestamp":1740441600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-025-13738-4","type":"journal-article","created":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T16:02:00Z","timestamp":1740499320000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Gem-TIP as a salvage therapy for pediatric extracranial malignant rhabdoid tumors: insights from a retrospective case series"],"prefix":"10.1186","volume":"25","author":[{"given":"Jian","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lulu","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tianjiao","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinrong","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qian","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiyang","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianfeng","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tao","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,2,25]]},"reference":[{"issue":"2","key":"13738_CR1","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1007\/s00431-023-05345-x","volume":"183","author":"S Xie","year":"2024","unstructured":"Xie S, Fang Y, Yang Y, et al. Extracranial malignant rhabdoid tumors in children: high mortality even with the help of an aggressive clinical approach. Eur J Pediatr. 2024;183(2):557\u201367.","journal-title":"Eur J Pediatr"},{"issue":"2","key":"13738_CR2","doi-asserted-by":"publisher","first-page":"111","DOI":"10.3171\/2019.9.PEDS19367","volume":"25","author":"K Yamasaki","year":"2020","unstructured":"Yamasaki K, Kiyotani C, Terashima K, et al. Clinical characteristics, treatment, and survival outcome in pediatric patients with atypical teratoid\/rhabdoid tumors: a retrospective study by the Japan Children\u2019s Cancer Group. J Neurosurg Pediatr. 2020;25(2):111\u201320.","journal-title":"J Neurosurg Pediatr"},{"issue":"9","key":"13738_CR3","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1016\/j.cancergen.2014.05.015","volume":"207","author":"A Uwineza","year":"2014","unstructured":"Uwineza A, Gill H, Buckley P, et al. Rhabdoid tumor: the Irish experience 1986\u20132013. Cancer Genet. 2014;207(9):398\u2013402.","journal-title":"Cancer Genet"},{"key":"13738_CR4","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.ejca.2016.02.027","volume":"60","author":"B Brennan","year":"2016","unstructured":"Brennan B, De Salvo GL, Orbach D, et al. Outcome of extracranial malignant rhabdoid tumours in children registered in the European Paediatric Soft Tissue Sarcoma Study Group Non-rhabdomyosarcoma Soft Tissue sarcoma 2005 Study-EpSSG NRSTS 2005. Eur J Cancer. 2016;60:69\u201382.","journal-title":"Eur J Cancer"},{"issue":"2","key":"13738_CR5","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1007\/s11060-008-9750-y","volume":"92","author":"P Fidani","year":"2009","unstructured":"Fidani P, De Ioris MA, Serra A, et al. A multimodal strategy based on surgery, radiotherapy, ICE regimen and high dose chemotherapy in atypical teratoid\/rhabdoid tumours: a single institution experience. J Neurooncol. 2009;92(2):177\u201383.","journal-title":"J Neurooncol"},{"issue":"5","key":"13738_CR6","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1097\/01.mph.0000212901.84146.5a","volume":"28","author":"M Yamamoto","year":"2006","unstructured":"Yamamoto M, Suzuki N, Hatakeyama N, et al. Treatment of stage IV malignant rhabdoid tumor of the kidney (MRTK) with ICE and VDCy: a case report. J Pediatr Hematol Oncol. 2006;28(5):286\u20139.","journal-title":"J Pediatr Hematol Oncol"},{"issue":"3","key":"13738_CR7","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1038\/bmt.2013.208","volume":"49","author":"M Benesch","year":"2014","unstructured":"Benesch M, Bartelheim K, Fleischhack G, et al. High-dose chemotherapy (HDCT) with auto-SCT in children with atypical teratoid\/rhabdoid tumors (AT\/RT): a report from the European Rhabdoid Registry (EU-RHAB). Bone Marrow Transpl. 2014;49(3):370\u20135.","journal-title":"Bone Marrow Transpl"},{"issue":"4","key":"13738_CR8","first-page":"537","volume":"48","author":"K Matsubara","year":"2021","unstructured":"Matsubara K, Yamasaki K, Tanimura K, et al. [Gemcitabine and Docetaxel for the treatment of relapsed and refractory malignant rhabdoid tumor of kidney and atypical Teratoid Rhabdoid Tumor]. Gan Kagaku Ryoho. 2021;48(4):537\u201340.","journal-title":"Gan Kagaku Ryoho"},{"issue":"12","key":"13738_CR9","doi-asserted-by":"publisher","first-page":"e29267","DOI":"10.1002\/pbc.29267","volume":"68","author":"M Steinb\u00fcgl","year":"2021","unstructured":"Steinb\u00fcgl M, Nemes K, Johann P, et al. Clinical evidence for a biological effect of epigenetically active decitabine in relapsed\/progression rhabdoid tumors. Pediatr Blood Cancer. 2021;68(12):e29267.","journal-title":"Pediatr Blood Cancer"},{"issue":"27","key":"13738_CR10","doi-asserted-by":"publisher","first-page":"6549","DOI":"10.1200\/JCO.2005.19.638","volume":"23","author":"GV Kondagunta","year":"2005","unstructured":"Kondagunta GV, Bacik J, Donadio A, et al. Combination of paclitaxel, ifosfamide, and cisplatin is an effective second-line therapy for patients with relapsed testicular germ cell tumors. J Clin Oncol. 2005;23(27):6549\u201355.","journal-title":"J Clin Oncol"},{"issue":"6","key":"13738_CR11","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1016\/j.clgc.2018.07.006","volume":"16","author":"HS McKenzie","year":"2018","unstructured":"McKenzie HS, Mead G, Huddart R, et al. Salvage Chemotherapy with Gemcitabine, Paclitaxel, Ifosfamide, and cisplatin for relapsed germ cell Cancer. Clin Genitourin Cancer. 2018;16(6):458\u2013e4652.","journal-title":"Clin Genitourin Cancer"},{"issue":"1","key":"13738_CR12","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1097\/MNM.0000000000000401","volume":"37","author":"M Aras","year":"2016","unstructured":"Aras M, Erdil TY, Dane F, et al. Comparison of WHO, RECIST 1.1, EORTC, and PERCIST criteria in the evaluation of treatment response in malignant solid tumors. Nucl Med Commun. 2016;37(1):9\u201315.","journal-title":"Nucl Med Commun"},{"key":"13738_CR13","doi-asserted-by":"publisher","first-page":"479","DOI":"10.2147\/CMAR.S289544","volume":"14","author":"K Nemes","year":"2022","unstructured":"Nemes K, Johann PD, T\u00fcchert S, et al. Current and emerging therapeutic approaches for Extracranial Malignant Rhabdoid tumors. Cancer Manag Res. 2022;14:479\u201398.","journal-title":"Cancer Manag Res"},{"issue":"4","key":"13738_CR14","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1080\/14728222.2018.1451839","volume":"22","author":"K Nemes","year":"2018","unstructured":"Nemes K, Fr\u00fchwald MC. Emerging therapeutic targets for the treatment of malignant rhabdoid tumors. Expert Opin Ther Targets. 2018;22(4):365\u201379.","journal-title":"Expert Opin Ther Targets"},{"issue":"3","key":"13738_CR15","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1002\/pbc.22857","volume":"57","author":"AD Trobaugh-Lotrario","year":"2011","unstructured":"Trobaugh-Lotrario AD, Finegold MJ, Feusner JH. Rhabdoid tumors of the liver: rare, aggressive, and poorly responsive to standard cytotoxic chemotherapy. Pediatr Blood Cancer. 2011;57(3):423\u20138.","journal-title":"Pediatr Blood Cancer"},{"issue":"8","key":"13738_CR16","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1002\/pbc.25093","volume":"61","author":"R Venkatramani","year":"2014","unstructured":"Venkatramani R, Shoureshi P, Malvar J, Zhou S, Mascarenhas L. High dose alkylator therapy for extracranial malignant rhabdoid tumors in children. Pediatr Blood Cancer. 2014;61(8):1357\u201361.","journal-title":"Pediatr Blood Cancer"},{"issue":"1","key":"13738_CR17","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/s00432-014-1760-x","volume":"141","author":"M Kurobe","year":"2015","unstructured":"Kurobe M, Kawai K, Oikawa T, et al. Paclitaxel, ifosfamide, and cisplatin (TIP) as salvage and consolidation chemotherapy for advanced germ cell tumor. J Cancer Res Clin Oncol. 2015;141(1):127\u201333.","journal-title":"J Cancer Res Clin Oncol"},{"issue":"5","key":"13738_CR18","first-page":"2191","volume":"32","author":"R Klapdor","year":"2012","unstructured":"Klapdor R, Klapdor S, Bahlo M. Combination therapy with gemcitabine (GEM) and erlotinib (E) in exocrine pancreatic cancer under special reference to RASH and the tumour marker CA19-9. Anticancer Res. 2012;32(5):2191\u20137.","journal-title":"Anticancer Res"},{"issue":"23s","key":"13738_CR19","doi-asserted-by":"publisher","first-page":"73","DOI":"10.2217\/fon-2016-0331","volume":"12","author":"C Spatola","year":"2016","unstructured":"Spatola C, Tocco A, Milazzotto R, et al. Role, timing and technique of radiotherapy in pediatric pleuropulmonary synovial sarcoma. Future Oncol. 2016;12(23s):73\u20137.","journal-title":"Future Oncol"},{"issue":"24 Suppl","key":"13738_CR20","doi-asserted-by":"publisher","first-page":"57","DOI":"10.2217\/fon.15.315","volume":"11","author":"C Spatola","year":"2015","unstructured":"Spatola C, Migliore M, Emanuele Liardo RL, et al. Follicular dendritic cell sarcoma of mediastinum: a key role of radiotherapy in a multidisciplinary approach. Future Oncol. 2015;11(24 Suppl):57\u201361.","journal-title":"Future Oncol"},{"issue":"1","key":"13738_CR21","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1002\/pbc.22285","volume":"54","author":"I Sultan","year":"2010","unstructured":"Sultan I, Qaddoumi I, Rodr\u00edguez-Galindo C, et al. Age, stage, and radiotherapy, but not primary tumor site, affects the outcome of patients with malignant rhabdoid tumors[J]. Pediatr Blood Cancer. 2010;54(1):35\u201340. https:\/\/doi.org\/10.1002\/pbc.22285.","journal-title":"Pediatr Blood Cancer"},{"issue":"7","key":"13738_CR22","doi-asserted-by":"publisher","first-page":"587","DOI":"10.3109\/08880018.2013.791737","volume":"30","author":"K Kerl","year":"2013","unstructured":"Kerl K, Holsten T, Fr\u00fchwald MC. Rhabdoid tumors: clinical approaches and molecular targets for innovative therapy[J]. Pediatr Hematol Oncol. 2013;30(7):587\u2013604. https:\/\/doi.org\/10.3109\/08880018.2013.791737.","journal-title":"Pediatr Hematol Oncol"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-13738-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-025-13738-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-13738-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T16:02:03Z","timestamp":1740499323000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-025-13738-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,25]]},"references-count":22,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["13738"],"URL":"https:\/\/doi.org\/10.1186\/s12885-025-13738-4","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,25]]},"assertion":[{"value":"23 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This retrospective study was approved by the Ethics Committee of Nanjing Medical University (Approval No.: [202410001-1]). The requirement for informed consent was waived due to the retrospective nature of the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"This study does not contain any identifiable personal data of participants; therefore, consent for publication was not required.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"348"}}